Zhu S, Rezvani M, Harbell J, Mattis A, Wolfe A, Benet L, et al. Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature. 2014;508:93-7 pubmed publisher

Hua Y, Yoshimochi K, Li J, Takekita K, Shimotsuma M, Li L, et al. Development and evaluation of a novel xeno-free culture medium for human-induced pluripotent stem cells. Stem Cell Res Ther. 2022;13:223 pubmed publisher

Tian P, Elefanty A, Stanley E, Durnall J, Thompson L, Elwood N. Creation of GMP-Compliant iPSCs From Banked Umbilical Cord Blood. Front Cell Dev Biol. 2022;10:835321 pubmed publisher

Ackermann M, Rafiei Hashtchin A, Manstein F, Carvalho Oliveira M, Kempf H, Zweigerdt R, et al. Continuous human iPSC-macrophage mass production by suspension culture in stirred tank bioreactors. Nat Protoc. 2022;17:513-539 pubmed publisher

Pagliaroli L, Porazzi P, Curtis A, Scopa C, Mikkers H, Freund C, et al. Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disorders. Nat Commun. 2021;12:6469 pubmed publisher

Kamand M, Ilieva M, Louise Forsberg S, Thomassen M, Meyer M, Fex Svenningsen A, et al. Derivation of induced pluripotent stem cells (SDUKIi003-A) from a 20-year-old male patient diagnosed with Asperger syndrome. Stem Cell Res. 2020;48:101974 pubmed publisher

Yu Z, Dmitrieva N, Walts A, Jin H, Liu Y, Ping X, et al. STAT3 modulates reprogramming efficiency of human somatic cells; insights from autosomal dominant Hyper IgE syndrome caused by STAT3 mutations. Biol Open. 2020;9: pubmed publisher

Kamand M, Ilieva M, Forsberg S, Thomassen M, Fex Svenningsen A, Holst B, et al. Generation of human induced pluripotent stem cells (SDUKIi002-A) from a 22-year-old male diagnosed with autism spectrum disorder. Stem Cell Res. 2020;46:101834 pubmed publisher

Döpper H, Horstmann M, Menges J, Bozet M, Kanber D, Steenpass L. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines. Stem Cell Res. 2020;45:101779 pubmed publisher

Petters J, Cimmaruta C, Iwanov K, Chang M, Völkner C, Knuebel G, et al. Generation of induced pluripotent stem cell lines AKOSi002-A and AKOSi003-A from symptomatic female adults with Wilson disease. Stem Cell Res. 2020;43:101708 pubmed publisher

Völkner C, Peter F, Liedtke M, Krohn S, Lindner I, Murua Escobar H, et al. Generation of the Niemann-Pick type C2 patient-derived iPSC line AKOSi001-A. Stem Cell Res. 2019;41:101606 pubmed publisher

Menges J, Cremanns M, Steenpass L. Generation of two H1 hESC sublines carrying deletions of RB1 exon 1/promoter in heterozygous or compound heterozygous state. Stem Cell Res. 2019;39:101517 pubmed publisher

Kuang Y, Muñoz A, Nalula G, Santostefano K, Sanghez V, Sanchez G, et al. Evaluation of commonly used ectoderm markers in iPSC trilineage differentiation. Stem Cell Res. 2019;37:101434 pubmed publisher

Simic M, Moehle E, Schinzel R, Lorbeer F, Halloran J, Heydari K, et al. Transient activation of the UPRER is an essential step in the acquisition of pluripotency during reprogramming. Sci Adv. 2019;5:eaaw0025 pubmed publisher

Schipper L, Kanber D, Steenpass L. Generation of heterozygous and homozygous hESC H9 sublines carrying inactivating mutations in RB1. Stem Cell Res. 2018;33:41-45 pubmed publisher

Neureiter A, Brändl B, Hiber M, Tandon R, Muller F, Steenpass L. Generation of an iPSC line of a patient with Angelman syndrome due to an imprinting defect. Stem Cell Res. 2018;33:20-24 pubmed publisher

Steenpass L. Generation of two H1 hESC sublines carrying a heterozygous and homozygous knock-out of RB1. Stem Cell Res. 2017;25:270-273 pubmed publisher